I-Heng Lee

I-Heng Lee has extensive experience in medical affairs, particularly in patient access, quality of care, and health economics. At Gilead Sciences, roles included Head of US Medical Affairs for Patient Access & Quality of Care, Head of Global Medical Affairs for Observational Research, and Executive Director and Co-Head of Medical Affairs for Health Economics & Outcomes Research from June 2019 to August 2020. Prior to Gilead, I-Heng Lee was a Regional Health Outcomes Manager for Vaccines in the Asia-Pacific and North Asia regions and a Product Manager for Respiratory products in New Zealand at GlaxoSmithKline from May 2011 to January 2015. Additional experience includes a Research Fellow position at Duke-NUS Graduate Medical School and a Research Assistant role at the University of North Carolina at Chapel Hill. I-Heng Lee's educational background includes courses in vaccinology and epidemiology.